Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx ®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting Interventions: Dietary Supplement: Vivomixx®; Dietary Supplement: Conjugated linoleic acid (CLA/Tonalin® FFA 80); Other: Maltose placebo; Other: Sunflower oil placebo Sponsor: Westfälische Wilhelms-Universität Münster Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Conjugated Linoleic Acid | Diets | Immunotherapy | Multiple Sclerosis | Nutrition | Omega 6 | Probiotics | Research